Hence, the observed inverse relationship between cetuximab-mediated ADCC and HLA-A expression reflects the nature of NK cell activation and aligns with a study in non-small cell lung cancer [42]. This evidence concerns the gene HLA-A and non-small cell lung carcinoma.